https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Gastroesophageal Reflux Disease

Showing all 9 results

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

The Chinese gastrointestinal (GI) endoscopic device market includes GI endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. High demand for GI screening and intervention procedures due to the aging population and growing awareness will drive market growth. Over the 2011–2018 forecast period, market expansion will be fueled by procedural growth and a higher incidence of GI disease; this will result in market growth accelerating gradually over the forecast period.

more...

Anti-Reflux Devices Market Report | United States | 2019-2025 | MedCore

The value of the anti-reflux device market increased in 2018, and strong growth is expected to continue over the forecast period. Growth will be driven by consistent unit sales growth and ASP appreciation. Anti-reflux devices covered in this analysis use a variety of procedure techniques to treat GERD, including transoral incisionless fundoplication (TIF), transesophageal radiofrequency

more...

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite (Includes 9 Reports)

Overall, the European gastrointestinal endoscopic devices market was valued at nearly €1.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.3% to reach just under €1.4 billion. The saturated nature of the European market for GI endoscopic devices will somewhat limit growth over the forecast period. Reimbursement

more...

Gastrointestinal Endoscopy Devices Market Size, Share & Trends Analysis | Global | 2019-2025 | 3 MedSuites | Includes: Gastrointestinal Endoscopes, Virtual Colonoscopy Software, Capsule Endoscopy, Stenting & Dilation, ERCP, Hemostasis, Enteral Feeding, Anti-Reflux & Barrett’s Esophagus Ablation Devices

This Global Report Series represents iData’s entire collection of country-level reports in the Gastrointestinal (GI) Endoscopy Devices Market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2019) Europe (2019) China (2020) US Gastrointestinal

more...

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite (Includes 13 reports)

Overall, the U.S. GI endoscopic device market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.5% to exceed $3.7 billion. As the demand side of the market continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the

more...

Capsule Endoscopy Market Analysis, Size, Trends | Global | 2019-2025 | MedCore

Industry Trends Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel. Modeled after advanced missile guidance technology, capsule endoscopy allows patients to undergo diagnostic procedures without any of the discomfort associated with conventional endoscopies. These procedures are noninvasive and typically painless. From 2001 to

more...

Anti-Reflux Devices Market Analysis | United States | 2017-2023 | MedCore

Following the exit of NDO Surgical, Curon Medical and C.R. Bard in the past, EndoGastric Solution was left to fill the void left by these companies. Utilizing an aggressive marketing campaign and a large sales expansion, the company was able to increase its market presence significantly. However, since then, two other companies have entered the market to compete for market share: Mederi Therapeutics which acquired Curon Medical and its Stretta® system after it filed for bankruptcy in 2010, and Torax Medical which received FDA approval for its LINX® system in 2012.

more...

Gastrointestinal Devices Product Portfolio and Pipeline | United States | 2017-2023 | MedFolio

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

more...

Gastrointestinal Devices Procedure Volume Analysis | United States | 2017-2023 | MedPro

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

more...